Parameter
| Biomarker | CYFRA21-1 | Full name | Cytokeratin 19 Fragment Antigen 21-1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis,condition monitoring |
| Disease | Non-Small Cell Lung Cancer | Disease Subtypes | / | ||
| Organ | Lung | Test Sample / Technology Platform | Serum (routine test) | ||
| Pathobiological Mechanisms | There is no specific mechanism and is expressed in both lung squamous cell carcinoma and non-squamous cell NSCLC | ||||
| Clinical Availability Status | Clinically available (condition monitoring) | ||||
| Notes and Dynamics | It can be used as an adjunctive surveillance indicator for NSCLC progression | ||||